de Miguel-Díez J, et al. - Using the RIETE (Registro Informatizado Enfermedad Trombo Embólica) database, researchers compared the mortality rate and the causes of death during anticoagulation in patients with pulmonary embolism (PE) according to the presence or absence of diabetes. They found that diabetes was correlated with increased rates for all-cause death. In addition, diabetes was related to a higher rate of arterial ischemic events. It was noted that higher mortality rate could not be attributed to diabetes itself. They discovered that the influence of arterial events or antiplatelet drugs (if any) was low. It was concluded that diabetes was not an independent predictor of death in the cohort of patients with PE.